LOADING
Tag: Delgocitinib
Delgocitinib Leads to Strong 16-Week Improvement in Chronic Hand Eczema – The American Journal of Managed Care® (AJMC®)
April 25, 2026
Delgocitinib Leads to Strong 16-Week Improvement in Chronic Hand Eczema The American Journal of Managed Care® (AJMC®) Source link
chat_bubble0 Comment
visibility4 Views
FDA Accepts sNDA for Delgocitinib Cream to Treat Pediatric Chronic Hand Eczema – Dermatology Times
April 15, 2026
FDA Accepts sNDA for Delgocitinib Cream to Treat Pediatric Chronic Hand Eczema Dermatology Times Source link
chat_bubble0 Comment
visibility9 Views
Delgocitinib Sustains Quality of Life Gains Through 52 Weeks in Chronic Hand Eczema – Dermatology Times
April 13, 2026
Delgocitinib Sustains Quality of Life Gains Through 52 Weeks in Chronic Hand Eczema Dermatology Times Source link
chat_bubble0 Comment
visibility12 Views
Delgocitinib Reduces Work and Activity Burden in CHE – Dermatology Times
March 6, 2026
Delgocitinib Reduces Work and Activity Burden in CHE Dermatology Times Source link
chat_bubble0 Comment
visibility26 Views